HIIFS
ARRY

Harel Insurance Investments & Financial Services’s Array Biopharma Inc ARRY Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-500
Closed -$3K – 470
2016
Q3 		$3K Buy
+500
New +$1.93K ﹤0.01% 444

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Harel Insurance Investments & Financial Services's ARRY Position: Q4 2016 in Review

Harel Insurance Investments & Financial Services sold out of Array Biopharma Inc (ARRY) in Q4 2016, closing a stake of 500 shares — an estimated $3K sold.

Harel Insurance Investments & Financial Services first reported a position in ARRY in Q3 2016 and held it in 1 quarter. The position peaked at $3K in Q3 2016. 167 funds tracked by Wall St. Rank hold ARRY as of Q4 2016.

  • Harel Insurance Investments & Financial Services reported no remaining Array Biopharma Inc position as of Q4 2016 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 500 Array Biopharma Inc shares in Q4 2016, an estimated $3K.
  • Harel Insurance Investments & Financial Services first reported a position in Array Biopharma Inc in Q3 2016 and held it in 1 quarter.
  • Harel Insurance Investments & Financial Services's Array Biopharma Inc position peaked at $3K in Q3 2016.
  • 167 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2016.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q4 2016, filed 6 Feb 2017.